BIOMAT Database Logo BIOMAT Database Logo

Preliminary experience with FK 506 in pancreas transplant recipients. 1995

R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
University of Nebraska Medical Center, Omaha 68198-3280, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D016035 Pancreas Transplantation The transference of a pancreas from one human or animal to another. Grafting, Pancreas,Transplantation, Pancreas,Graftings, Pancreas,Pancreas Grafting,Pancreas Graftings,Pancreas Transplantations,Transplantations, Pancreas
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report.
April 1996, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Neurotoxicity of FK 506 in liver transplant recipients.
April 1993, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Gastrointestinal toxicity associated with FK 506 in liver transplant recipients.
December 1994, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Lipids following pancreas transplantation in recipients receiving FK 506.
December 1995, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Early infections in kidney transplant recipients under FK 506.
February 1991, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Clinical study of FK 506 in renal transplant recipients.
November 2000, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Monitoring of FK 506 blood levels in kidney transplant recipients.
August 1994, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.
June 1994, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
December 1991, Transplantation proceedings,
R J Stratta, and R J Taylor, and P Castaldo, and R Sindhi, and D Sudan, and K Frisbie, and K Cushing
Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506.
February 1991, Transplantation proceedings,
Copied contents to your clipboard!